Puricore's business, which is based on selling sterilisation technology to food retailers and medical device users, grew impressively during the year, as supermarkets and hospitals made increasing use of the company's cleansing technology.
IC TIP:
Hold
at
10p
Sales were up 80 per cent to $33m (£22.5m), with pre-tax losses narrowing to $15.7m from $21.3m. Net cash at the year-end stood at $8.5m. Cost savings, including pay freezes, helped to reduce cash outflow to $6.6m, down from $14.1m. The US food business contributed the bulk of the growth and generated contract extensions worth $11.1m from its biggest customers.
